ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

In Brief: Gori to Return As Head Of Smoking Program; Wisconsin, AACI To Honor Harold Rusch

May 18, 1979

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010